Canonic Announces Pre-Launch of Medical Cannabis Products in Israel

Canonic Ltd, a company focused on the development of products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation inflorescence products, reported PRNewswire.

Canonic is a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN) developing products through a Computational Predictive Biology (CPB) platform, aimed at improving active compounds yield, genetic …

Full story available on Benzinga.com

More Canonic Announces Pre-Launch of Medical Cannabis Products in Israel